I first came across the legal dispute regarding ATM Metabolics’ Emulin supplement in our recently published iGalen review.

A reader got in contact with some additional information, prompting me to further research the dispute.

Here’s what I found.

ATM Metabolics claims to provide “real solutions for metabolic disorders”. The company is based out of Florida and headed up by CEO Joseph Ahrens.

ATM Metabolics are the supplier of Emulin, which up until recently was a flagship product of iGalen.

From around mid 2018, ATM Metabolics began also supplying Valentus with Emulin.

Owing to an exclusivity clause in their contract, iGalen filed suit against ATM Metabolics in November 2018.

iGalen’s lawsuit was filed in the Superior Court of 
California
 for the County of 
San Diego. The case isn’t tracked on Pacer and I wasn’t able to track down a copy of the complaint elsewhere.

As per a “
Corporate Legal Announcement
” dated May 21st however, iGalen CEO Rajen Manicka confirms the lawsuit is a contract dispute.

Towards the end of the announcement, Manicka reveals iGalen sent Valentus a cease and desist notice on May 20th.

As per the notice, Valentus has 72 hours to stop selling Emulin.

As I write this there’s no mention of Emulin on the product section of Valentus’ website.

There is however a Prevail 24/7 Carb Burner product advertised. Joseph Ahrens and ATM Metabolics are heavily featured in Valentus’ 24/7 Carb Burner marketing.

Although I can’t say for sure, I believe Prevail 24/7 Carb Burner is just another name for Emulin.

If Valentus failed to comply with their cease and desist, iGalen threatened to add Valentus as a defendant in their lawsuit.

Whether or not that happened in unclear. Ditto the overall status of iGalen’s ongoing case.

On April 15th ATM Metabolics filed its own lawsuit against iGalen, parent company Holista Colltech Limited, Rajen Manicka and Kosta Gara (iGalen’s Chief Executive Advisor).

Note that ATM Metabolics’ lawsuit makes a distinction between Holista Colltech and iGalen.

For the sake of simplicity I’m just going to refer to Holista Colltech as iGalen going forward.

If you want to read more on the relationship between iGalen and Holista Colltech, check out of recently published
iGalen review
.

As per ATM Metabolics lawsuit, a five-year contract between iGalen and ATM Metabolics was entered into on January 9th, 2017.

This Agreement granted iGalen, in part, the exclusive right to market, promote, and sell Emulin in the Multi-Level-Marketing space throughout the world, in exchange, in pertinent part, for royalty payments.

ATM Metabolics alleges that iGalen has violated the contract, by failing

to meet its contractual obligations since the inception of the Agreement, and has strung ATM along for more than one year with promises (that would eventually prove to be false) that Holista’s poor performance would improve.

ATM Metabolics claims iGalen’s sales “have been well-below expectations”, and that the company has

🤖 Quick Answer

What was the legal dispute between iGalen, Valentus, and ATM Metabolics regarding Emulin?
iGalen filed suit against ATM Metabolics in November 2018 in San Diego Superior Court. The dispute arose after ATM Metabolics, Emulin's supplier, began supplying the supplement to competitor Valentus around mid-2018, allegedly violating an exclusivity clause in their contract with iGalen.

Who headed ATM Metabolics during the Emulin dispute?
ATM Metabolics was headed by CEO Joseph Ahrens. The Florida-based company positioned itself as a provider of solutions for metabolic disorders and served as the primary supplier of the Emulin supplement to multiple distributors.

🔗 Related Articles

- BlackOxygen Organics class-action alleges supplement toxicity
- SEC use Sloan’s post TelexFree activity against her
- Talk Fusion terminate top ranked affiliates, lawsuit filed
- Achieve Community investors receive chargeback refunds?
- De La Rosa & Crosby preliminary injunction granted